| Q30669342 | (1)H MR Spectroscopy of Meningiomas at 3.0T: the Role of Glutamate-Glutamine Complex and Glutathione |
| Q48338205 | Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases. |
| Q37465431 | Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by ¹H HR-MAS NMR Metabolomics |
| Q38709622 | Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems |
| Q42860801 | Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours? |
| Q33631468 | Characterizing human cancer metabolomics with ex vivo 1H HRMAS MRS. |
| Q62489264 | Computational Approaches in Theranostics: Mining and Predicting Cancer Data |
| Q53587011 | Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer. |
| Q48578191 | Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma |
| Q35529046 | Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues |
| Q36903783 | Metabolic phenotyping and systems biology approaches to understanding neurological disorders |
| Q38227841 | Metabolomic studies of human gastric cancer: review |
| Q47205404 | Metabolomics technology and bioinformatics for precision medicine. |
| Q37462435 | Metabolomics: moving to the clinic |
| Q39404690 | Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation |
| Q93108710 | NMR Spectroscopy for Metabolomics Research |
| Q37799274 | NMR methods for unravelling the spectra of complex mixtures |
| Q57016043 | NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations |
| Q38088723 | Nuclear magnetic resonance-based analysis of urine for the rapid etiological diagnosis of pneumonia |
| Q33785024 | Pediatric meningioma: current approaches and future direction. |
| Q34591157 | Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. |
| Q33744117 | pH optimization for a reliable quantification of brain tumor cell and tissue extracts with 1H NMR: focus on choline-containing compounds and taurine |